Media Summary: The dynamic landscape of molecular biology has bolstered gene- Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, describes Given their potential to treat severe and rare diseases, cell and gene

Addressing The Challenges Of Therapeutic Vector Development - Detailed Analysis & Overview

The dynamic landscape of molecular biology has bolstered gene- Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, describes Given their potential to treat severe and rare diseases, cell and gene 0:29 in vivo nucleic acid delivery: 1:10 Why? 2:35 How? 4:40 What? 5:52 in vivo jetPEI®: easy, injectable, safe 9:40 in vivo ... Michael Lehmicke, Senior Director of Science & Industry Affairs, Alliance for Regenerative Medicine, Washington, D.C., comments ... Presented By: Carl Dargitz & Magda Tomala Speaker Biography: Carl Dargitz is a Manager in the Cell & Gene

Lawrence Forman, Founder and CEO CHO Plus, Inc. is a privately held company founded in 2014 with the mission of increasing ... Casey Maguire, PhD, Associate Professor of Neurology, Harvard Medical School, Investigator, Associate Professor of Neurology, ... The Business of Biotech kicks off our Cell & Gene Miniseries with Dr. Carsten Brunn, President & CEO at Selecta Biosciences. Alan Beggs, PhD Director of the Manton Center for Orphan Disease Research Sir Edwin and Lady Manton Professor of Pediatrics, ... Virtual Mini-Conference: “COMMERCIALIZATION OF CELL & GENE This panel from the 2024 CGT Summit hosted by Charles River Laboratories brings together experts from Moonlight Bio, ...

In this poster presented at ASGCT 2026, Philipp Beck explores how formulation optimization can reduce

Photo Gallery

Addressing the Challenges of Therapeutic Vector Development
Cytiva
Challenges in manufacturing viral vectors for the clinic
Practical strategies for overcoming challenges in the development of AAV vectors for gene therapy
Addressing the challenges of cell and gene therapy manufacturing
[Webinar] in vivo delivery from study to gene therapy
CMC challenges in cell and gene therapy manufacturing
Addressing common challenges in lentiviral vector clarification using closed, automated counter....
Gene Therapy Vectors
CHO Plus
AAV Vector Delivery Strategies for Peripheral Nerves
The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
Sponsored
Sponsored
View Detailed Profile
Addressing the Challenges of Therapeutic Vector Development

Addressing the Challenges of Therapeutic Vector Development

The dynamic landscape of molecular biology has bolstered gene-

Cytiva

Cytiva

Jenny Pchelinski, Business

Sponsored
Challenges in manufacturing viral vectors for the clinic

Challenges in manufacturing viral vectors for the clinic

Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, describes

Practical strategies for overcoming challenges in the development of AAV vectors for gene therapy

Practical strategies for overcoming challenges in the development of AAV vectors for gene therapy

Gene

Addressing the challenges of cell and gene therapy manufacturing

Addressing the challenges of cell and gene therapy manufacturing

Given their potential to treat severe and rare diseases, cell and gene

Sponsored
[Webinar] in vivo delivery from study to gene therapy

[Webinar] in vivo delivery from study to gene therapy

0:29 in vivo nucleic acid delivery: 1:10 Why? 2:35 How? 4:40 What? 5:52 in vivo jetPEI®: easy, injectable, safe 9:40 in vivo ...

CMC challenges in cell and gene therapy manufacturing

CMC challenges in cell and gene therapy manufacturing

Michael Lehmicke, Senior Director of Science & Industry Affairs, Alliance for Regenerative Medicine, Washington, D.C., comments ...

Addressing common challenges in lentiviral vector clarification using closed, automated counter....

Addressing common challenges in lentiviral vector clarification using closed, automated counter....

Presented By: Carl Dargitz & Magda Tomala Speaker Biography: Carl Dargitz is a Manager in the Cell & Gene

Gene Therapy Vectors

Gene Therapy Vectors

Dr. David Williams 2025 Annual

CHO Plus

CHO Plus

Lawrence Forman, Founder and CEO CHO Plus, Inc. is a privately held company founded in 2014 with the mission of increasing ...

AAV Vector Delivery Strategies for Peripheral Nerves

AAV Vector Delivery Strategies for Peripheral Nerves

Casey Maguire, PhD, Associate Professor of Neurology, Harvard Medical School, Investigator, Associate Professor of Neurology, ...

The AAV Vector Challenge With Selecta's Dr. Carsten Brunn

The AAV Vector Challenge With Selecta's Dr. Carsten Brunn

The Business of Biotech kicks off our Cell & Gene Miniseries with Dr. Carsten Brunn, President & CEO at Selecta Biosciences.

SCIENCE SLAM: INNOVATING AAV VECTORS TO ACHIEVE BETTER GENE THERAPY OUTCOMES

SCIENCE SLAM: INNOVATING AAV VECTORS TO ACHIEVE BETTER GENE THERAPY OUTCOMES

As the use of gene

Workshop: It’s Never Too Soon–Considerations for Gene Therapy Manufacturing in the Early Stages

Workshop: It’s Never Too Soon–Considerations for Gene Therapy Manufacturing in the Early Stages

The success of gene

Ch 3: Mitigation Strategies to Address the Challenges in the Development of Gene Therapy Programs

Ch 3: Mitigation Strategies to Address the Challenges in the Development of Gene Therapy Programs

Alan Beggs, PhD Director of the Manton Center for Orphan Disease Research Sir Edwin and Lady Manton Professor of Pediatrics, ...

Manufacturing Hurdles with Viral Vectors

Manufacturing Hurdles with Viral Vectors

With a wide range of viral

Navigating the Process Development Challenges of Cell & Gene Therapy

Navigating the Process Development Challenges of Cell & Gene Therapy

Virtual Mini-Conference: “COMMERCIALIZATION OF CELL & GENE

Viral Vector Gene Therapy: From Discovery to Commercialization

Viral Vector Gene Therapy: From Discovery to Commercialization

This panel from the 2024 CGT Summit hosted by Charles River Laboratories brings together experts from Moonlight Bio, ...

Formulation optimization reduces cannula-associated vector loss during precision AAV brain delivery

Formulation optimization reduces cannula-associated vector loss during precision AAV brain delivery

In this poster presented at ASGCT 2026, Philipp Beck explores how formulation optimization can reduce

Overcoming Challenges in AAV and LV Viral Vector Manufacturing

Overcoming Challenges in AAV and LV Viral Vector Manufacturing

Overcoming